Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis.

Cheng JW, Cheng SW, Gao LD, Lu GC, Wei RL.

PLoS One. 2012;7(9):e45079. doi: 10.1371/journal.pone.0045079. Epub 2012 Sep 13. Review.

PMID:
23028770
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.

Stewart WC, Konstas AG, Nelson LA, Kruft B.

Ophthalmology. 2008 Jul;115(7):1117-1122.e1. Epub 2008 Feb 20.

PMID:
18082886
[PubMed - indexed for MEDLINE]
3.

Efficacy and tolerability of latanoprost compared to dorzolamide combined with timolol in the treatment of patients with elevated intraocular pressure: a meta-analysis of randomized, controlled trials.

Cheng JW, Xi GL, Wei RL, Cai JP, Li Y.

J Ocul Pharmacol Ther. 2009 Feb;25(1):55-64. doi: 10.1089/jop.2008.0080.

PMID:
19232016
[PubMed - indexed for MEDLINE]
4.

The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.

Orzalesi N, Rossetti L, Bottoli A, Fumagalli E, Fogagnolo P.

Arch Ophthalmol. 2003 Apr;121(4):453-7.

PMID:
12695241
[PubMed - indexed for MEDLINE]
5.

Intraocular pressure-lowering effect of adding dorzolamide or latanoprost to timolol: a meta-analysis of randomized clinical trials.

Webers CA, van der Valk R, Schouten JS, Zeegers MP, Prins MH, Hendrikse F.

Ophthalmology. 2007 Jan;114(1):40-6. Epub 2006 Oct 27.

PMID:
17070584
[PubMed - indexed for MEDLINE]
6.

Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.

van der Valk R, Webers CA, Schouten JS, Zeegers MP, Hendrikse F, Prins MH.

Ophthalmology. 2005 Jul;112(7):1177-85.

PMID:
15921747
[PubMed - indexed for MEDLINE]
7.

Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.

Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.

Curr Med Res Opin. 2009 Jul;25(7):1645-53. doi: 10.1185/03007990902994041.

PMID:
19476406
[PubMed - indexed for MEDLINE]
8.
9.

Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.

Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A, Gandolfo E.

Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2917-23.

PMID:
16799034
[PubMed - indexed for MEDLINE]
Free Article
10.

A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.

Facio AC, Reis AS, Vidal KS, de Moraes CG, Suzuki R, Hatanaka M, Susanna R.

J Ocul Pharmacol Ther. 2009 Oct;25(5):447-51. doi: 10.1089/jop.2009.0018.

PMID:
19860553
[PubMed - indexed for MEDLINE]
11.

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.

PMID:
12795627
[PubMed - indexed for MEDLINE]
12.

The intraocular pressure-lowering effect of prostaglandin analogs combined with topical β-blocker therapy: a systematic review and meta-analysis.

Webers CA, Beckers HJ, Zeegers MP, Nuijts RM, Hendrikse F, Schouten JS.

Ophthalmology. 2010 Nov;117(11):2067-74.e1-6. doi: 10.1016/j.ophtha.2010.03.024. Review.

PMID:
20619459
[PubMed - indexed for MEDLINE]
13.

Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.

Shin DH, Feldman RM, Sheu WP; Fixed Combination Latanoprost/Timolol Study Group.

Ophthalmology. 2004 Feb;111(2):276-82.

PMID:
15019375
[PubMed - indexed for MEDLINE]
14.
15.

Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.

Li N, Chen XM, Zhou Y, Wei ML, Yao X.

Clin Experiment Ophthalmol. 2006 Nov;34(8):755-64.

PMID:
17073898
[PubMed - indexed for MEDLINE]
16.

Meta-analysis of medical intervention for normal tension glaucoma.

Cheng JW, Cai JP, Wei RL.

Ophthalmology. 2009 Jul;116(7):1243-9. doi: 10.1016/j.ophtha.2009.01.036. Epub 2009 May 17.

PMID:
19450880
[PubMed - indexed for MEDLINE]
17.
18.

Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.

Holló G, Kóthy P.

Curr Med Res Opin. 2008 Jun;24(6):1755-61. doi: 10.1185/03007990802159273. Epub 2008 May 13.

PMID:
18479590
[PubMed - indexed for MEDLINE]
19.

Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.

Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A.

Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2566-73.

PMID:
10937568
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk